IRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milano, Italy.
Consiglio Nazionale delle Ricerche-Istituto di Chimica Biomolecolare (CNR-ICB), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy.
Mar Drugs. 2022 Feb 11;20(2):135. doi: 10.3390/md20020135.
Longer life expectancy has led to an increase in efforts directed to the discovery of new healing agents for disorders related to aging, such as bone diseases. Harboring an incredible variety of bioactive metabolites, marine organisms are standing out as fruitful sources also in this therapeutic field. On the other hand, the in vivo zebrafish model has proven to be an excellent low-cost screening platform for the fast identification of molecules able to regulate bone development. By using zebrafish larvae as a mineralization model, we have thus evaluated the effects of the crude acetonic extract from the marine sponge and its bromotyrosine components on bone development. Obtained results led to the selection of aerophobin-1 () as a promising candidate for applications in regenerative medicine, paving the way for the development of a novel therapeutic option in osteoporosis treatment.
预期寿命的延长促使人们努力寻找新的治疗药物,以应对与衰老相关的疾病,如骨疾病。海洋生物拥有令人难以置信的多种生物活性代谢物,它们在治疗领域也成为了富有成效的资源。另一方面,体内斑马鱼模型已被证明是一种用于快速鉴定能够调节骨骼发育的分子的低成本筛选平台。我们使用斑马鱼幼虫作为矿化模型,评估了海洋海绵的粗丙酮提取物及其溴代酪氨酸成分对骨骼发育的影响。研究结果选择了 Aerophobin-1()作为再生医学应用的有前途的候选物,为骨质疏松症治疗的新型治疗选择开辟了道路。